Growth Metrics

Vivos (RDGL) Shares Outstanding (Weighted Average) (2010 - 2025)

Vivos recorded quarterly Shares Outstanding (Weighted Average) of $452.7 million in Q4 2025, little changed quarter-over-quarter from $452.0 million in Q3 2025, and up 1481.89% year-over-year from $28.6 million in Q4 2024.

Vivos' Shares Outstanding (Weighted Average) history runs 16 years deep, the most recent figure standing at $452.7 million for Q4 2025.

  • In Q4 2025, Shares Outstanding (Weighted Average) rose 1481.89% year-over-year to $452.7 million; the TTM figure through Dec 2025 stood at $452.7 million (up 1481.89% YoY), while the FY2025 annual figure was $452.7 million, up 1481.89% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $452.7 million for Q4 2025 at Vivos, roughly flat from $452.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $453.5 million in Q2 2025 to a low of $1.3 million in Q3 2021.
  • A 5-year average of $308.7 million and a median of $357.0 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
  • Across the five-year window, Shares Outstanding (Weighted Average) tumbled 99.39% in 2021 and soared 26102.4% in 2022, its largest moves.
  • Vivos' Shares Outstanding (Weighted Average) stood at $325.9 million in 2021, then increased by 7.85% to $351.4 million in 2022, then increased by 4.95% to $368.8 million in 2023, then tumbled by 92.24% to $28.6 million in 2024, then jumped by 1481.89% to $452.7 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $452.7 million, $452.0 million, and $453.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.74 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 382.90 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 456.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 98.20 Mn
10 Vivos - - -3,105.00 452.72 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 452.72 Mn
Sep 30, 2025 452.04 Mn
Jun 30, 2025 453.51 Mn
Mar 31, 2025 448.23 Mn
Dec 31, 2024 28.62 Mn
Sep 30, 2024 418.63 Mn
Jun 30, 2024 24.53 Mn
Mar 31, 2024 389.41 Mn
Dec 31, 2023 368.81 Mn
Sep 30, 2023 370.54 Mn
Jun 30, 2023 368.17 Mn
Mar 31, 2023 362.54 Mn
Dec 31, 2022 351.43 Mn
Sep 30, 2022 343.91 Mn
Jun 30, 2022 343.76 Mn
Mar 31, 2022 343.61 Mn
Dec 31, 2021 325.85 Mn
Sep 30, 2021 1.31 Mn
Jun 30, 2021 314.45 Mn
Mar 31, 2021 11.24 Mn
Dec 31, 2020 222.80 Mn
Sep 30, 2020 213.42 Mn
Jun 30, 2020 2.20 Mn
Mar 31, 2020 4.40 Mn
Dec 31, 2019 150,000.00
Sep 30, 2019 172.44 Mn
Jun 30, 2019 169.69 Mn
Mar 31, 2019 166.15 Mn
Dec 31, 2018 55.50 Mn
Sep 30, 2018 22.75 Mn
Jun 30, 2018 11.04 Mn
Mar 31, 2018 66.51 Mn
Dec 31, 2017 48.39 Mn
Sep 30, 2017 52.47 Mn
Jun 30, 2017 42.38 Mn
Mar 31, 2017 38.02 Mn
Dec 31, 2016 21.50 Mn
Sep 30, 2016 19.99 Mn
Jun 30, 2016 19.98 Mn
Mar 31, 2016 19.97 Mn
Dec 31, 2015 18.51 Mn
Sep 30, 2015 19.42 Mn
Jun 30, 2015 1.95 Bn
Mar 31, 2015 16.01 Mn
Dec 31, 2014 16.01 Mn
Sep 30, 2014 228.88 Mn
Jun 30, 2014 131.47 Mn
Mar 31, 2014 106.65 Mn
Dec 31, 2013 100.69 Mn
Sep 30, 2013 95.85 Mn
Jun 30, 2013 97.65 Mn
Mar 31, 2013 86.85 Mn
Dec 31, 2012 75.67 Mn
Sep 30, 2012 74.44 Mn
Jun 30, 2012 76.66 Mn
Mar 31, 2012 74.94 Mn
Dec 31, 2011 69.35 Mn
Sep 30, 2011 68.99 Mn
Jun 30, 2011 68.89 Mn
Mar 31, 2011 68.15 Mn
Dec 31, 2010 56.17 Mn
Sep 30, 2010 54.16 Mn
Jun 30, 2010 53.55 Mn